Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.86 USD | -2.11% | -13.86% | -52.54% |
10/05 | UBS Cuts Price Target on ACADIA Pharmaceuticals to $25 From $27, Keeps Buy Rating | MT |
10/05 | Oppenheimer Adjusts ACADIA Pharmaceuticals Price Target to $17 From $19, Maintains Perform Rating | MT |